Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 94 results

Search term: MF = 'C_{33}H_{49}N_{3}O_{4}S'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
22779165

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H49N3O4S/c1-6-23-41(39,40)35(22-17-26(3)4)25-32(37)36(24-29-16-12-11-13-27(29)5)30-18-20-34(21-19-30)33(38)31(7-2)28-14-9-8-10-15-28/h8-16,26,30-31H,6-7,17-25H2,1-5H3
C33H49N3O4S583.82497600
25068392

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H49N3O4S/c1-7-26-23-36(18-19-41(6,39)40)30-16-15-27(21-28(26)30)32(38)35-29(20-25-13-9-8-10-14-25)31(37)22-34-33(4,5)17-11-12-24(2)3/h8-10,13-16,21,23-24,29,31,34,37H,7,11-12,17-20,22H2,1-6H3,(H,35,38)/t29-,31+/m0/s1
C33H49N3O4S583.82492200
419843

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H49N3O4S/c1-3-25-40-33(37)36(26-28-13-7-4-8-14-28)31-20-23-35(24-21-31)22-19-30(29-15-9-5-10-16-29)27-34(2)41(38,39)32-17-11-6-12-18-32/h5-6,9-12,15-18,28,30-31H,3-4,7-8,13-14,19-27H2,1-2H3
C33H49N3O4S583.82492200
8992412

Charge

Double-bond stereo
InChI=1/C17H14N2O4S.C16H36N/c1-23-16-10-7-12-11-14(24(20,21)22)8-9-15(12)17(16)19-18-13-5-3-2-4-6-13;1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4/h2-11H,1H3,(H,20,21,22);5-16H2,1-4H3/q;+1/p-1/b19-18+;
C33H49N3O4S583.82491100
16521704

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-8-9-10-14-20-36(31(38)28(19-21-41-7)35-32(39)40-33(4,5)6)29(27-18-17-24(2)22-25(27)3)30(37)34-23-26-15-12-11-13-16-26/h11-13,15-18,22,28-29H,8-10,14,19-21,23H2,1-7H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521705

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-9-10-11-14-20-36(31(38)28(19-21-41-8)35-32(39)40-33(5,6)7)29(26-18-17-23(2)22-25(26)4)30(37)34-27-16-13-12-15-24(27)3/h12-13,15-18,22,28-29H,9-11,14,19-21H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521719

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-8-9-10-14-21-36(31(38)28(20-22-41-7)35-32(39)40-33(4,5)6)29(27-19-15-16-24(2)25(27)3)30(37)34-23-26-17-12-11-13-18-26/h11-13,15-19,28-29H,8-10,14,20-23H2,1-7H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521720

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-9-10-11-14-21-36(31(38)28(20-22-41-8)35-32(39)40-33(5,6)7)29(26-18-15-17-23(2)25(26)4)30(37)34-27-19-13-12-16-24(27)3/h12-13,15-19,28-29H,9-11,14,20-22H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521734

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-8-9-10-14-20-36(31(38)28(19-21-41-7)35-32(39)40-33(4,5)6)29(27-18-17-24(2)25(3)22-27)30(37)34-23-26-15-12-11-13-16-26/h11-13,15-18,22,28-29H,8-10,14,19-21,23H2,1-7H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521735

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-9-10-11-14-20-36(31(38)28(19-21-41-8)35-32(39)40-33(5,6)7)29(26-18-17-23(2)25(4)22-26)30(37)34-27-16-13-12-15-24(27)3/h12-13,15-18,22,28-29H,9-11,14,19-21H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521749

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-8-9-10-14-21-36(31(38)27(20-22-41-7)35-32(39)40-33(4,5)6)29(28-24(2)16-15-17-25(28)3)30(37)34-23-26-18-12-11-13-19-26/h11-13,15-19,27,29H,8-10,14,20-23H2,1-7H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521750

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-9-10-11-14-21-36(31(38)27(20-22-41-8)35-32(39)40-33(5,6)7)29(28-24(3)17-15-18-25(28)4)30(37)34-26-19-13-12-16-23(26)2/h12-13,15-19,27,29H,9-11,14,20-22H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521764

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-8-9-10-14-20-36(31(38)28(19-21-41-7)35-32(39)40-33(4,5)6)29(27-22-24(2)17-18-25(27)3)30(37)34-23-26-15-12-11-13-16-26/h11-13,15-18,22,28-29H,8-10,14,19-21,23H2,1-7H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521765

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H49N3O4S/c1-9-10-11-14-20-36(31(38)28(19-21-41-8)35-32(39)40-33(5,6)7)29(26-22-23(2)17-18-24(26)3)30(37)34-27-16-13-12-15-25(27)4/h12-13,15-18,22,28-29H,9-11,14,19-21H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521798

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C33H49N3O4S/c1-22(2)18-19-25(5)36(31(38)27(20-21-41-9)34-32(39)40-33(6,7)8)29(26-16-11-10-12-17-26)30(37)35-28-23(3)14-13-15-24(28)4/h10-17,22,25,27,29H,18-21H2,1-9H3,(H,34,39)(H,35,37)
C33H49N3O4S583.82491100
16521824

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C33H49N3O4S/c1-23(2)18-19-25(4)36(31(38)28(20-21-41-8)35-32(39)40-33(5,6)7)29(27-17-13-12-14-24(27)3)30(37)34-22-26-15-10-9-11-16-26/h9-17,23,25,28-29H,18-22H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521825

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C33H49N3O4S/c1-22(2)18-19-25(5)36(31(38)28(20-21-41-9)35-32(39)40-33(6,7)8)29(26-16-12-10-14-23(26)3)30(37)34-27-17-13-11-15-24(27)4/h10-17,22,25,28-29H,18-21H2,1-9H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521839

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C33H49N3O4S/c1-23(2)17-18-25(4)36(31(38)28(19-20-41-8)35-32(39)40-33(5,6)7)29(27-16-12-13-24(3)21-27)30(37)34-22-26-14-10-9-11-15-26/h9-16,21,23,25,28-29H,17-20,22H2,1-8H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
16521840

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C33H49N3O4S/c1-22(2)17-18-25(5)36(31(38)28(19-20-41-9)35-32(39)40-33(6,7)8)29(26-15-12-13-23(3)21-26)30(37)34-27-16-11-10-14-24(27)4/h10-16,21-22,25,28-29H,17-20H2,1-9H3,(H,34,37)(H,35,39)
C33H49N3O4S583.82491100
100223185

Double-bond stereo
InChI=1/C33H49N3O4S/c1-3-5-7-9-11-16-22-39-30-21-20-28(24-31(30)40-23-17-12-10-8-6-4-2)25-34-36-33(38)27-41-26-32(37)35-29-18-14-13-15-19-29/h13-15,18-21,24-25H,3-12,16-17,22-23,26-27H2,1-2H3,(H,35,37)(H,36,38)/b34-25-
C33H49N3O4S583.82491100
12345

Advertisement